Cases & Deals

Takeda acquires Ariad Pharmaceuticals for $5.2 billion

Clients Takeda Pharmaceuticals U.S.A., Inc.

Jones Day advised Takeda Pharmaceuticals U.S.A., Inc. on intellectual property matters relating to its $5.2 billion acquisition of Ariad Pharmaceuticals.